Does USTEKINUMAB Cause Swollen joint count increased? 1,571 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,571 reports of Swollen joint count increased have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.8% of all adverse event reports for USTEKINUMAB.
1,571
Reports of Swollen joint count increased with USTEKINUMAB
1.8%
of all USTEKINUMAB reports
951
Deaths
953
Hospitalizations
How Dangerous Is Swollen joint count increased From USTEKINUMAB?
Of the 1,571 reports, 951 (60.5%) resulted in death, 953 (60.7%) required hospitalization, and 1,054 (67.1%) were considered life-threatening.
Is Swollen joint count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,571 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Swollen joint count increased?
METHOTREXATE (2,068)
ABATACEPT (2,032)
TOCILIZUMAB (1,987)
RITUXIMAB (1,973)
ADALIMUMAB (1,933)
DICLOFENAC (1,916)
LEFLUNOMIDE (1,907)
FOLIC ACID (1,898)
PREDNISONE (1,882)
ALENDRONATE (1,880)
Which USTEKINUMAB Alternatives Have Lower Swollen joint count increased Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE